Floating tablets of nimodipine and its inclusion complex with β-cyclodextrin for controlled release

International Journal of PharmTech Research

Volumn 3, Issue 2, 2011, Pages 619-625

  Patil, Ajaykumar ^a   Majahar, Shaik ^a   Irfani, Gulam ^a  

^a KARNATAKA COLLEGE OF PHARMACY   (India)

Author keywords

cyclodextrin; Complexation; Floating tablet; Nimodipine; Phase solubility

Indexed keywords

BETA CYCLODEXTRIN; BICARBONATE; CALCIUM PHOSPHATE DIBASIC; EUDRAGIT; MAGNESIUM STEARATE; NIMODIPINE; WATER;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; STOMACH; TABLET FORMULATION;

EID: 79960952836     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Baumgartner S, Kristl J, Vrecer F, Vodopivec P, Zorko B., Optimization of floating matrix tablets and evaluation of their gastric residence time, Int J Pharm, 2000, 195, 125-135.
2. Iannuccelli V, Coppi G, Bernabei M.T, Cameroni R., Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study, Int J Pharm, 1998, 174, 47-54.
3. Santus G, Lazzarini G, Bottoni G., An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations, Eur J Pharm Biopharm, 1997, 44, 39-52.
4. Deshpande A.A, Rhodes C.T, Shah N.H, Malick A.W., Controlled-release drug delivery systems for prolonged gastric residence: an overview, Drug Dev Ind Pharm, 1996, 22, 531-540.
5. Deshpande A.A, Shah N.H, Rhodes C.T, Malick W., Development of a novel controlled-release system for gastric retention, Pharm Res, 1997, 14, 815-819.
6. Menon A, Ritschel W.A, Sakr A., Development and evaluation of a monolithic floating dosage form for furosemide, J Pharm Sci, 1994, 83, 239-245.
7. Whitehead L, Fell J.T, Collett J.H, Sharma H.L, Smith A.M., Floating dosage forms:an in vivo study demonstrating prolonged gastric retention, J Control Release, 1998, 55, 3-12.
8. Singh B and Kim K., Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release, 2000, 63, 235-259.
9. Chawla G and Bansal A., A means to address regional variability in intestinal drug absorption, Pharm Technol, 2003, 2, 50-68.
10. Chowdary K.P.R and Reddy G.K., Investigation of complexation of nimodipine with β-and hydroxypropyl β-cyclodextrins, Indian Drugs, 2001, 38(11), 555-558.
11. Fatemah A, Mohammedi A, Dinarvand R., Preparation of nimodipine loaded microspheres: Evaluation of parameters, Iranian J of pharmaceutical sciences, 2005, 1(3), 143-152.
12. Higuchi T and Connors K.A., Phase-solubility techniques, Adva Anal Chem Instr, 1965, 4, 117.
13. Chowdary K.P.R, RamanaMurthy K.V and Prasad D.S, Solid dispersions of Nimodipine: Physico-chemical and dissolution rate studies, Indian Drugs, 1995, 32(11), 537-542.
14. Khan K.A., The concept of dissolution efficiency, J Pharm Pharmacol, 1975, 27, 48-49.
15. th Edn., Pharmacopoeial Convention, Inc., Rockvillie. MD., USA, 2000, 1942.
16. Gohel C.M, Mehta R.P, Dave K.R. and Bariya H.N., Dissolution Technologies, 2004, 11(4), 22-25.